The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

HHS' decision "could stagnate research that has the potential to save millions of lives," writes Simon Williams.

STONY BROOK, NY / ACCESS Newswire / August 14, 2025 /Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production ...

STONY BROOK, NY / / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions ...

But a novel technique is allowing us to peer back further than DNA's expiration date in Africa, to answer long-standing ...

At two gene loci the researchers studied, increased looping in the absence of ORC2 isolated a known gene enhancer from the ...

Shifting from its pandemic response origins, the market is diversifying into new vaccines and oncology. Asset-light biotechs fuel this growth, making ...

A new discovery about mutations in a gene that causes ALS may allow researchers to design targeted therapies, a study found.

RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against infection ...

It may be time to rethink certain genetic mutations associated with two devastating neurodegenerative disorders—amyotrophic ...

Scientists once dismissed the theory that traits acquired during life could be inherited, but with new evidence and hypotheses, it’s seeing a resurgence.

The U.S. Department of Health and Human Services announced on Tuesday that it will cancel $500 million worth of projects dedicated to designing messenger RNA (mRNA) vaccines for pandemic preparedness.